Wei Jiang - 12 Aug 2025 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Reporting relationship: Director
Issuer ticker: STAA
Reported as of: 12 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Aug 2025, 18:39:57 UTC
Prior SEC filing: 01 Jul 2025
Next SEC filing: 02 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Nathaniel Sisitsky as attorney-in-fact for Wei Jiang

Key filing fact

Wei Jiang filed Form 4 for STAAR SURGICAL CO (STAA) on 13 Aug 2025.

Key facts

This page summarizes Wei Jiang's Form 4 filing for STAAR SURGICAL CO (STAA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Aug 2025, 18:39.

Change

Previous filing in this sequence was filed on 01 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001867980 Primary reporting owner

Jiang Wei

Relationship: Director
Address: 25510 COMMERCENTRE DRIVE, LAKE FOREST
Signature: /s/ Nathaniel Sisitsky as attorney-in-fact for Wei Jiang
Signature date: 13 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STAA transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +20,967
Change %: +592%
Price: $0.000000
Shares after: 24,510
Date: 12 Aug 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STAA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -20,967
Change %: -33%
Price: $0.000000
Shares after: 41,934
Date: 12 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,967
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025, and will vest as to 1/3 (20,967 shares) on November 12, 2025, and 1/3 (20,967 shares) on January 12, 2026.

Footnote F2

Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.

SEC remarks

As disclosed in the Corporation's Current Report on Form 8-K filed on April 24, 2025, the Corporation entered into a consulting agreement with Mr. Jiang to serve as a special strategic advisor to the Corporation's Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy. This Form 4 reflects the vesting of RSUs granted to Mr. Jiang in connection with such service.